HEALTHEQUITY, INC.
HEALTHEQUITY, INC.
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Financial Statements
Values in Millions ($) | 2026-04-30 | 2026-01-31 | 2025-10-31 | 2025-07-31 | 2025-04-30 | 2025-01-31 | 2024-10-31 | 2024-07-31 | 2024-04-30 | 2024-01-31 | 2023-10-31 | 2023-07-31 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Financial statements beyond 3 years are for subscribers only. Unlock 17+ years of income statements, balance sheets, and cash flow statements Start 7-day free trial |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Assets | |||||||||||||||||
Assets Current | |||||||||||||||||
Cash And Cash Equivalents At Carrying Value | 265 | 319 | 309 | 304 | 288 | 296 | 322 | 327 | 251 | 404 | 334 | 290 | |||||
Accounts Receivable Net Current | 122 | 124 | 111 | 111 | 116 | 118 | 107 | 108 | 106 | 105 | 96 | 93 | |||||
Other Assets Current | - | - | - | - | - | 64 | 66 | 60 | 47 | 49 | 44 | 40 | |||||
Prepaid Expense And Other Assets Current | 79 | 70 | 78 | 77 | 69 | 64 | - | - | - | - | - | - | |||||
Assets Current | 467 | 512 | 499 | 493 | 473 | 478 | 495 | 496 | 405 | 557 | 474 | 423 | |||||
Property Plant And Equipment Net | 4 | 3 | 3 | 3 | 3 | 3 | 4 | 5 | 5 | 6 | 8 | 9 | |||||
Operating Lease Right Of Use Asset | 35 | 36 | 38 | 40 | 41 | 43 | 45 | 46 | 48 | 48 | 50 | 52 | |||||
Intangible Assets Net Excluding Goodwill | 1,073 | 1,097 | 1,125 | 1,152 | 1,179 | 1,205 | 1,228 | 1,254 | 1,071 | 836 | 861 | 882 | |||||
Goodwill | 1,648 | 1,648 | 1,648 | 1,648 | 1,648 | 1,648 | 1,648 | 1,648 | 1,648 | 1,648 | 1,648 | 1,648 | |||||
Other Assets Noncurrent | 80 | 83 | 85 | 80 | 71 | 72 | 68 | 65 | 69 | 68 | 52 | 53 | |||||
Assets | 3,306 | 3,380 | 3,398 | 3,417 | 3,416 | 3,449 | 3,488 | 3,514 | 3,246 | 3,164 | 3,094 | 3,066 | |||||
Liabilities And Stockhold… | |||||||||||||||||
Liabilities Current | |||||||||||||||||
Accounts Payable Current | 14 | 12 | 20 | 10 | 13 | 14 | 10 | 11 | 18 | 12 | 13 | 13 | |||||
Employee Related Liabilities Current | 27 | 60 | 44 | 32 | 24 | 69 | 48 | 37 | 23 | 50 | 31 | 31 | |||||
Accrued Liabilities Current | 85 | 74 | 47 | 65 | 68 | 63 | 87 | 63 | 41 | 46 | 42 | 49 | |||||
Long Term Debt Current | - | - | - | - | - | - | - | - | - | 0 | 0 | 0 | |||||
Operating Lease Liability Current | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 9 | 10 | 10 | |||||
Liabilities Current | 136 | 157 | 121 | 117 | 116 | 156 | 155 | 121 | 92 | 117 | 96 | 103 | |||||
Liabilities Noncurrent | |||||||||||||||||
Long Term Debt Noncurrent | 943 | 957 | 982 | 1,007 | 1,057 | 1,056 | 1,081 | 1,101 | 926 | 875 | 874 | 874 | |||||
Operating Lease Liability Noncurrent | 32 | 34 | 36 | 38 | 40 | 42 | 44 | 46 | 48 | 49 | 51 | 52 | |||||
Other Liabilities Noncurrent | 53 | 31 | 24 | 22 | 22 | 23 | 25 | 25 | 19 | 19 | 18 | 13 | |||||
Deferred Income Tax Liabilities Net | 95 | 94 | 102 | 87 | 57 | 56 | 59 | 63 | 63 | 69 | 67 | 75 | |||||
Liabilities Noncurrent | 1,123 | 1,116 | 1,143 | 1,154 | 1,176 | 1,177 | 1,209 | 1,237 | 1,056 | 1,012 | 1,009 | 1,014 | |||||
Liabilities | 1,259 | 1,273 | 1,264 | 1,270 | 1,292 | 1,334 | 1,364 | 1,357 | 1,149 | 1,129 | 1,106 | 1,117 | |||||
Stockholders Equity | |||||||||||||||||
Preferred Stock Value | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Common Stock Value | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Additional Paid In Capital | 1,902 | 1,917 | 1,917 | 1,919 | 1,905 | 1,906 | 1,893 | 1,887 | 1,863 | 1,829 | 1,809 | 1,785 | |||||
Retained Earnings Accumulated Deficit | 177 | 196 | 208 | 227 | 218 | 209 | 232 | 270 | 234 | 206 | 179 | 165 | |||||
Accumulated Other Comprehensive Income Loss Net Of… | -32 | -6 | 9 | 0 | - | 0 | - | - | - | - | - | - | |||||
Stockholders Equity | 2,047 | 2,107 | 2,134 | 2,146 | 2,124 | 2,115 | 2,125 | 2,157 | 2,098 | 2,035 | 1,988 | 1,950 | |||||
Liabilities And Stockholders Equity | 3,306 | 3,380 | 3,398 | 3,417 | 3,416 | 3,449 | 3,488 | 3,514 | 3,246 | 3,164 | 3,094 | 3,066 | |||||
Allowance For Doubtful Accounts Receivable Current | 1 | 1 | 1 | 1 | 1 | 2 | 3 | 3 | 4 | 4 | 5 | 5 | |||||
Preferred Stock Par Or Stated Value Per Share | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Preferred Stock Shares Authorized | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | |||||
Preferred Stock Shares Issued | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Preferred Stock Shares Outstanding | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Common Stock Par Or Stated Value Per Share | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Common Stock Shares Authorized | 900 | 900 | 900 | 900 | 900 | 900 | 900 | 900 | 900 | 900 | 900 | 900 | |||||
Common Stock Shares Issued | 84 | 85 | 86 | 86 | 87 | 87 | 87 | 87 | 87 | 86 | 86 | 86 | |||||
Shares Outstanding | 84 | 85 | 86 | 86 | 87 | 87 | 87 | 87 | 87 | 86 | 86 | 86 | |||||
Subscribe to unlock 17+ years of financial data, unlimited metrics, and saved tables
Subscribe to unlock 17+ years of data, unlimited metrics, and saved tables
Custom Table
Subscribe to unlock 17+ years of financial data, unlimited metrics, transformations, and saved visuals
Subscribe to unlock 17+ years of data, unlimited metrics, transformations, and saved visuals
Interactive Financial Visualizations
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Earnings Market Reaction
| Fiscal Year | Q1 1 Month | Q1 2 Month | Q1 3 Month | Q2 1 Month | Q2 2 Month | Q2 3 Month | Q3 1 Month | Q3 2 Month | Q3 3 Month | Q4 1 Month | Q4 2 Month | Q4 3 Month |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2027 | -5.87% | 7.90% | - | - | - | - | - | - | - | - | - | - |
| 2026 | 1.08% | -7.44% | -13.43% | 8.64% | 8.61% | 14.70% | -5.23% | -14.73% | -20.02% | -1.81% | 6.85% | 11.68% |
| 2025 | 6.13% | -0.30% | -5.66% | 1.65% | 12.01% | 32.58% | -3.50% | 9.33% | 8.67% | -19.15% | -11.08% | 9.72% |
| 2024 | -3.43% | -0.90% | 4.24% | 9.29% | 6.21% | 2.47% | -3.94% | 11.37% | 19.14% | 0.28% | -2.89% | 7.06% |
Earnings Market Reaction data beyond 3 years is for subscribers only. Unlock the full earnings market reaction history Start 7-day free trial | ||||||||||||
Subscribe to unlock 17+ years of financial data and 90+ calculated metrics
Subscribe to unlock 17+ years of data and 90+ calculated metrics
Performance and Valuation Metrics
Rows marked with a lock icon are subscribers only — subscribe to unlock 90+ calculated metrics and 17+ years of history.
Metrics | 2026-04-30 | 2026-01-31 | 2025-10-31 | 2025-07-31 | 2025-04-30 | 2025-01-31 | 2024-10-31 | 2024-07-31 | 2024-04-30 | 2024-01-31 | 2023-10-31 | 2023-07-31 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Metric history beyond 3 years is for subscribers only. Unlock 17+ years of history across 90+ calculated metrics Start 7-day free trial |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Liquidity Ratios | |||||||||||||||||
| Current Ratio | 3.44 | 3.27 | 4.13 | 4.23 | 4.06 | 3.06 | 3.20 | 4.10 | 4.39 | 4.76 | 4.93 | 4.09 | |||||
| Quick Ratio | 2.85 | 2.82 | 3.49 | 3.57 | 3.47 | 2.65 | 3.20 | 4.10 | 4.39 | 4.76 | 4.93 | 4.09 | |||||
| Working Capital | 330.79M | 355.43M | 378.08M | 376.26M | 356.45M | 321.43M | 340.71M | 374.72M | 312.69M | 440.35M | 378.17M | 319.29M | |||||
Leverage & Debt | |||||||||||||||||
| Debt to Equity | 0.61 | 0.60 | 0.59 | 0.59 | 0.61 | 0.63 | 0.64 | 0.63 | 0.55 | 0.55 | 0.56 | 0.57 | |||||
| Interest Coverage TTM | 6.24 | 5.64 | 4.97 | 3.71 | 3.20 | 2.68 | 2.70 | 3.13 | 2.61 | 2.12 | 1.64 | 1.22 | |||||
| Debt Ratio | 0.38 | 0.38 | 0.37 | 0.37 | 0.38 | 0.39 | 0.39 | 0.39 | 0.35 | 0.36 | 0.36 | 0.36 | |||||
Efficiency & Turnover | |||||||||||||||||
| Asset Turnover TTM | 0.40 | 0.38 | 0.37 | 0.37 | 0.37 | 0.36 | 0.35 | 0.33 | 0.33 | 0.32 | 0.32 | 0.31 | |||||
| Days Sales Outstanding TTM | 32.52 | 33.58 | 30.82 | 31.59 | 32.66 | 33.91 | 32.19 | 33.38 | 35.81 | 36.83 | 34.56 | 35.61 | |||||
| Receivables Turnover TTM | 11.22 | 10.87 | 11.84 | 11.56 | 11.17 | 10.77 | 11.34 | 10.93 | 10.19 | 9.91 | 10.56 | 10.25 | |||||
Per Share Metrics | |||||||||||||||||
| Diluted EPS TTM | 2.71 | 2.46 | 2.21 | 1.66 | 1.38 | 1.09 | 1.09 | 1.19 | 0.91 | 0.64 | 0.33 | 0.15 | |||||
| Free Cash Flow Per Share TTM | 5.78 | 5.28 | 4.80 | 4.22 | 3.90 | 3.89 | 3.89 | 3.50 | 3.17 | 2.82 | 2.56 | 2.46 | |||||
| Dividend Per Share TTM | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||||
Margin Metrics | |||||||||||||||||
| Gross Profit Margin TTM | 70.68% | 69.52% | 67.72% | 66.43% | 65.52% | 64.78% | 65.33% | 64.93% | 63.42% | 62.29% | 61.32% | 60.04% | |||||
| Operating Profit Margin TTM | 25.60% | 24.55% | 22.74% | 18.48% | 16.39% | 13.53% | 13.83% | 15.50% | 13.06% | 11.77% | 9.48% | 7.11% | |||||
| Net Profit Margin TTM | 17.25% | 16.38% | 14.86% | 11.49% | 9.80% | 8.06% | 8.41% | 9.61% | 7.71% | 5.57% | 3.00% | 1.37% | |||||
Growth Metrics | |||||||||||||||||
| Net Revenue Growth (1Y) | 7.58% | 9.47% | 12.20% | 15.45% | 19.21% | 20.03% | 18.47% | 17.19% | 15.80% | 16.00% | 16.82% | 17.97% | |||||
| Net Income Growth (1Y) | 89.40% | 122.54% | 98.37% | 38.01% | 51.44% | 73.58% | 231.86% | 723.95% | -1,056.37% | -313.10% | -149.60% | -120.64% | |||||
| EPS Growth (1Y) | 94.43% | 124.44% | 101.13% | 38.94% | 51.12% | 70.97% | 226.17% | 708.84% | -1,040.42% | -310.31% | -148.95% | -120.37% | |||||
Valuation Metrics | |||||||||||||||||
| P/E TTM | 30.01 | 34.29 | 42.40 | 57.57 | 60.98 | 99.19 | 76.87 | 64.71 | 84.84 | 116.08 | 210.81 | 453.11 | |||||
| P/B TTM | 3.38 | 3.50 | 3.81 | 3.91 | 3.50 | 4.54 | 3.50 | 3.17 | 3.25 | 3.18 | 3.09 | 2.98 | |||||
| P/S TTM | 5.18 | 5.62 | 6.30 | 6.62 | 5.98 | 7.99 | 6.46 | 6.22 | 6.54 | 6.47 | 6.33 | 6.20 | |||||
| Market Cap | 6.92B | 7.38B | 8.13B | 8.40B | 7.43B | 9.59B | 7.43B | 6.84B | 6.82B | 6.47B | 6.14B | 5.81B | |||||
| Enterprise Value | 7.60B | 8.02B | 8.81B | 9.10B | 8.20B | 10.35B | 8.19B | 7.61B | 7.50B | 6.94B | 6.68B | 6.39B | |||||
Calculated Values | |||||||||||||||||
| Free Cash Flow TTM | 487.64M | 455.13M | 412.96M | 365.42M | 337.72M | 337.77M | 338.87M | 305.17M | 274.43M | 241.13M | 219.71M | 210.49M | |||||
| Net Debt | 677.29M | 638.45M | 672.85M | 702.37M | 768.67M | 760.35M | 758.88M | 774.51M | 674.45M | 470.99M | 540.21M | 583.24M | |||||
Per-Share and Margin | |||||||||||||||||
| EPS TTM | |||||||||||||||||
| Adjusted EPS TTM | |||||||||||||||||
| Cash Flow Per Share TTM | |||||||||||||||||
| Pretax Margin TTM | |||||||||||||||||
| Stock Comp to Revenue TTM | |||||||||||||||||
Turnover Ratios and Averages | |||||||||||||||||
| Average Assets | |||||||||||||||||
| Average Equity | |||||||||||||||||
| Average Inventory | |||||||||||||||||
| Average Receivables | |||||||||||||||||
| Average Accounts Payables | |||||||||||||||||
| Inventory Turnover TTM | |||||||||||||||||
| Payables Turnover TTM | |||||||||||||||||
| Days Inventory Outstanding TTM | |||||||||||||||||
| Days Payables Outstanding TTM | |||||||||||||||||
| Cash Conversion Cycle TTM | |||||||||||||||||
| Working Capital to Revenue | |||||||||||||||||
| Deferred Revenue to Revenue | |||||||||||||||||
Growth Rates | |||||||||||||||||
| Total Assets Growth (1Y) | |||||||||||||||||
| Total Assets Growth (3Y) | |||||||||||||||||
| Total Assets Growth (5Y) | |||||||||||||||||
| Dividends Paid Growth (1Y) | |||||||||||||||||
| Dividends Paid Growth (3Y) | |||||||||||||||||
| Dividends Paid Growth (5Y) | |||||||||||||||||
| EPS Growth (3Y) | |||||||||||||||||
| EPS Growth (5Y) | |||||||||||||||||
| Net Income Growth (3Y) | |||||||||||||||||
| Net Income Growth (5Y) | |||||||||||||||||
| Net Profit Margin Growth (1Y) | |||||||||||||||||
| Net Profit Margin Growth (3Y) | |||||||||||||||||
| Net Profit Margin Growth (5Y) | |||||||||||||||||
| Net Revenue Growth (3Y) | |||||||||||||||||
| Net Revenue Growth (5Y) | |||||||||||||||||
| Deferred Revenue Growth (1Y) | |||||||||||||||||
| Retained Earnings Growth (1Y) | |||||||||||||||||
Credit, Liquidity, Returns, Payout | |||||||||||||||||
| Cash Ratio | |||||||||||||||||
| Net Working Capital | |||||||||||||||||
| Debt to EBITDA TTM | |||||||||||||||||
| Net Debt to EBITDA TTM | |||||||||||||||||
| Net Debt to Equity | |||||||||||||||||
| Altman A | |||||||||||||||||
| Altman B | |||||||||||||||||
| Altman C | |||||||||||||||||
| Altman D | |||||||||||||||||
| Altman E | |||||||||||||||||
| Altman Z-Score | |||||||||||||||||
| ROA TTM | |||||||||||||||||
| ROE TTM | |||||||||||||||||
| NOPAT TTM | |||||||||||||||||
| ROIC TTM | |||||||||||||||||
| Effective Tax Rate TTM | |||||||||||||||||
| Payout Ratio TTM | |||||||||||||||||
| Dilution Ratio | |||||||||||||||||
| Retained Earnings to Equity | |||||||||||||||||
| Treasury Stock to Equity | |||||||||||||||||
| Treasury Stock Change (1Y) | |||||||||||||||||
| Accrued to Current Liabilities | |||||||||||||||||
| NCAV | |||||||||||||||||
| NCAV Per Share TTM | |||||||||||||||||
Valuation Ratios | |||||||||||||||||
| P/CF TTM | |||||||||||||||||
| Dividend Yield TTM | |||||||||||||||||
| Free Cash Flow Yield TTM | |||||||||||||||||
| EV EBITDA TTM | |||||||||||||||||
| EV EBIT TTM | |||||||||||||||||
| Stock Compensation TTM | |||||||||||||||||
| Adjusted Net Income TTM | |||||||||||||||||
| Billings TTM | |||||||||||||||||
| Total Debt | |||||||||||||||||
| Invested Capital | |||||||||||||||||
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Insider Transactions
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Institutional Ownership
HEALTHEQUITY, INC. (HQY) — SEC Financial Statements & Analysis
HEALTHEQUITY, INC. (HQY) is a services-business services, nec company, incorporated in DE. HEALTHEQUITY, INC. trades on Nasdaq as: HQY. Based on its latest SEC filing (Form 10-Q, period ending 2026-04-30), HEALTHEQUITY, INC. reported a 7.58% year-over-year revenue growth, a Gross Profit Margin of 70.68% (TTM), a Debt-to-Equity ratio of 0.61x, a Price-to-Sales (P/S) ratio of 5.18x (TTM), a Price-to-Book (P/B) ratio of 3.38x (TTM), at a market cap of $6.92B. Figures below are sourced from SEC EDGAR, as-filed.
- Net Revenue TTM Growth 1Y
- 7.58%
- Gross Profit Margin TTM
- 70.68%
- Debt To Equity
- 0.61x
- P/S TTM
- 5.18x
- P/B TTM
- 3.38x
- Market Cap
- $6.92B
Data as of 2026-04-30 · Source: SEC EDGAR
Frequently Asked Questions
What industry is HEALTHEQUITY, INC. in?
HEALTHEQUITY, INC. (HQY) operates in the Services-Business Services, NEC industry.
What is HQY's market cap?
HEALTHEQUITY, INC. (HQY) has a market capitalization of $6.92B as of 2026-04-30.
What is HQY's P/E ratio?
HEALTHEQUITY, INC. (HQY)'s trailing twelve month P/E ratio is 30.01x as of 2026-04-30.
What exchange does HQY trade on?
HEALTHEQUITY, INC. (HQY) trades on the Nasdaq.
Where is HEALTHEQUITY, INC. incorporated?
HEALTHEQUITY, INC. is incorporated in DE.